$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The detailed price of moboxetinib succinate in 2024 has been released
2026-02-01 22:25:32
Check Details
shock! Is moboxetinib withdrawn from the market?
2026-02-01 22:25:32
Check Details
Must-read for patients: Overview of basic information in the instructions for mobosertinib
2026-02-01 22:25:32
Check Details
What are the precautions for moboxetinib?
2026-02-01 22:25:32
Check Details
I already know the news! Latest launch date of Moboxertinib
2026-02-01 22:25:32
Check Details
Who is the manufacturer of Mobosetinib and is it effective?
2026-02-01 22:25:32
Check Details
One thing patients must know when taking the drug: the efficacy and role of moboxetinib
2026-02-01 22:25:32
Check Details
Mobosetinib/mobosetinib drug donation policy
2026-02-01 22:25:32
Check Details
Which is better, moboxetinib or suvotinib?
2026-02-01 22:25:32
Check Details
Can I take moboxetinib with ex20 mutation?
2026-02-01 22:25:32
Check Details
The difference between the targeted drugs moboxetinib and erlotinib
2026-02-01 22:25:32
Check Details
Learn about the indications of Moboxetinib Capsules.
2026-02-01 22:25:32
Check Details
1
2
...
425
426
427
428
429
430
431
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
2
Opicapone Contraindications: Essential Restrictions for At-Risk Groups
3
Finerenone: An Innovative Treatment for Diabetic Kidney Disease
4
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
5
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
6
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
7
Sirolimus (Rapamune) Comprehensive Clinical Guide
8
Lusutrombopag Efficacy, Dosage and Storage Instructions
9
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
10
Cemiplimab (Libtayo) Drug Information
11
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
12
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia